18 and older, any sex, with Melena or Gastrointestinal Hemorrhage. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Time to Localization of BleedingPrimary· Enrollment to localization of bleeding as measured in hours, up to 720 hours, whichever is sooner.
Time to localization of bleeding refers to the time after a patient is admitted to the emergency room and a bleeding source is localized. We defined localization of bleeding as endoscopic visualization of stigmata of recent hemorrhage.
Group
Value
95% CI
Early Video Capsule Endoscopy
21
9 – 31
Standard of Care Workup Group
16
13 – 31
Number of Participants With Localization of Bleeding by the End of AdmissionSecondary· Patient's will be assessed for the duration of their hospital stay and for thirty days afterwards.
This measurement counts the number of participants with a bleeding source localized by the end of admission.
Group
Value
95% CI
Early Video Capsule Endoscopy
27
Standard of Care Workup Group
15
Sponsor's own description
The objectives of this study are to test whether there are statistically significant differences between the standard of care workup workup of non-hematemesis gastrointestinal bleeding by endoscopy \[upper, lower and other tests\], compared with deployment of a video capsule as the first test followed by the most appropriate endoscopic procedure based on video capsule findings, if needed. The investigators propose to examine differences in time to diagnosis, reduction in numbers of procedures, and length of stay between a standard of care workup protocol and our proposed protocol of early capsule endoscopy deployment.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Massachusetts, Worcester
Last refreshed: 7 August 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02442830.